Please select the option that best describes you:

Would you start once-weekly tirzepatide over once daily basal insulin in a patient with Type 2 diabetes with inadequate control on oral antihyperglycemia drugs?  



Answer from: at Academic Institution
Comments
at Goodendos
In addition, GLP-1 agents have shown  decreas...
Sign in or Register to read more